Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

MEMORY PHARMACEUTICALS CORP (MEMY) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $0.17 Metrics
OS: 72.6 M
Market cap: $12.3 M
Net cash: $1.45 M $0.02 per share
EV: $10.9 M

 
TTM Valuation
EBITDA ($40.9) M
EBIT ($42.6) M
EPS ($467.26)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-07Dec-31-06Dec-31-05Dec-31-04Dec-31-03Dec-31-02
Revenues11.59.311.19.87.61.2
            Revenue growth23.6%-16.1%13.6%28.4%544.0% 
Cost of goods sold9.38.48.47.47.14.5
Gross profit2.20.92.72.40.5-3.3
            Gross margin19.1%9.4%24.0%24.4%6.7%-279.5%
General and administrative9.38.48.47.47.14.5
EBIT-36.2-32.9-31.0-24.6-22.1-25.3
            EBIT margin-313.9%-353.2%-279.1%-251.4%-290.4%-2135.0%
Pre-tax income-35.3-31.5-31.9-24.3-22.0-25.1
Income taxes0.0-0.4-0.2-0.2-0.20.0
            Tax rate 1.2%0.7%1.0%0.8% 
Net income-35.3-31.10.00.00.00.0
            Net margin-306.3%-333.7%-0.3%-0.3%-0.4%-2.6%
 
Diluted EPS($0.49)($0.70)($1.20)($1.67)($30.07)($48.10)
Shares outstanding (diluted)71.944.30.00.00.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy